Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

EMA Reports Vials of Falsified Herceptin Identified

April 16, 2014 8:41 am | News | Comments

The European Medicines Agency (EMA) has been informed that vials of the cancer medicine Herceptin (trastuzumab), thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries.

TOPICS:

Study Finds Signs of Brain Changes in Pot Smokers

April 16, 2014 8:35 am | by MALCOLM RITTER, AP Science Writer | News | Comments

A small study of casual marijuana smokers has turned up evidence of changes in the brain, a possible sign of trouble ahead, researchers say. The young adults who volunteered for the study were not dependent on pot, nor did they show any marijuana-related problems.

TOPICS:

Judge Blocks Massachusetts Ban on Painkiller

April 16, 2014 8:26 am | by STEVE LeBLANC, Associated Press | News | Comments

The judge issued a preliminary injunction Tuesday after Zogenix argued in a lawsuit that the ban issued by Gov. Deval Patrick is unconstitutional. The judge said Massachusetts appears to have overstepped its authority in banning a federally approved medication.

TOPICS:
Advertisement

BioAlliance Pharma and Topotarget Announce Merger Agreement

April 16, 2014 8:22 am | News | Comments

BioAlliance Pharma SA and Topotarget A/S today announced their intention to merge to create an orphan oncology company with a highly complementary pipeline of late-stage products addressing significant unmet medical needs.     

TOPICS:

QIAGEN Announces Facility Changes

April 16, 2014 8:13 am | News | Comments

QIAGEN today announced plans to combine its three Maryland sites into two campuses and invest an additional $10 million to accommodate expected future growth. The company will close its current site at Gaithersburg, Maryland and move the Gaithersburg activities to nearby Germantown, Maryland, by early 2015.

TOPICS:

Epirus and Zalicus Announce Merger Agreement

April 16, 2014 8:08 am | News | Comments

Epirus Biopharmaceuticals, Inc. and Zalicus Inc., announced today that they have entered into a definitive agreement under which Epirus will merge with a wholly-owned subsidiary of Zalicus in an all-stock transaction.      

TOPICS:

FDA Approves Injectable Diabetes Drug from Glaxo

April 15, 2014 5:32 pm | by The Associated Press | News | Comments

The FDA has approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The agency cleared the company's drug, Tanzeum, to help patients control their blood sugar levels, in combination with diet and exercise.  

TOPICS:

Fluid Imaging Technologies Announces Call for Submissions for First Annual Life Sciences & Materials Research Grant

April 15, 2014 4:25 pm | by Fluid Imaging Technologies Inc. | News | Comments

Laboratory instrumentation manufacturer Fluid Imaging Technologies is pleased to announce the call for submissions for its Life Sciences & Materials Research Grant.                                      

Advertisement

Ductless Fume Hoods

April 15, 2014 4:21 pm | by Nikita Ernst, Associate Editor | Air Science Usa | Product Releases | Comments

The new PURAIR 5 Ductless Fume Hoods feature a high level of operator protection where routine histology, powder weighing and sampling prep work is being carried out.

DNA Alternative to Pap Smear Sparks Medical Debate

April 15, 2014 1:41 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen U.S. patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.  

TOPICS:

Manufacturing Technology Orders Down in February

April 15, 2014 8:49 am | News | Comments

February U.S. manufacturing technology orders totaled $354.40 million according to AMT - The Association For Manufacturing Technology. This total, as reported by companies participating in the USMTO program, was down 6.6% from January and down 6.2% when compared with the total of $377.82 million reported for February 2013. With a year-to-date total of $733.82 million, 2014 is down 0.6% compared with 2013.

TOPICS:

Prosonix Licenses Products to Mylan

April 15, 2014 8:45 am | News | Comments

PSX1001 and PSX1050, which are the first products to emerge from Prosonix's innovative and proprietary particle engineering platform, are being developed as generic versions to GlaxoSmithKline's pressurized metered dose inhalers (pMDI) Flixotide® and Flovent®, respectively.

TOPICS:

MERS Virus Outbreak Raises Alarm in Middle East

April 15, 2014 8:36 am | Videos | Comments

There's heightened concern after the confirmation of more cases of the deadly Middle East Respiratory Syndrome, or MERS, in Saudi Arabia and Jordan over the weekend.                

TOPICS:

The Dangers of Testing Ebola

April 15, 2014 8:22 am | Videos | Comments

Report details the dangers of testing Ebola, which has already claimed the lives of 14 healthcare workers.                        

TOPICS:

Report Projects Health Care Costs to Dip Slightly

April 15, 2014 8:13 am | by ANDREW TAYLOR, Associated Press | News | Comments

The Congressional Budget Office predicts that health insurance subsidies under the so-called "Obamacare" plan will total a little more than $1 trillion over the next 10 years, instead of almost $1.2 trillion initially estimated.    

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading